Compare BioNTech SE - ADR (BNTX) vs PulteGroup, Inc. (PHM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs PulteGroup, Inc. — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while PulteGroup, Inc. trades at $132.77 (market cap $25.22B). The key difference: BioNTech SE - ADR and PulteGroup, Inc. are close in size by market cap, and PulteGroup, Inc. pays a 0.79% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | PHM | |
|---|---|---|
Market Cap | $23.31B | $25.22B |
Sector | Health | Consumer Cyclical |
52-Week High | $119.34 | $142.56 |
52-Week Low | $83.89 | $110.11 |
Enterprise Value | $6.60B | $25.64B |
Dividend Yield | — | 0.79% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About PulteGroup, Inc.
PulteGroup Inc is one of the largest homebuilders in the United States, operating in 40 markets across 23 states. The company mainly builds single-family detached homes (85% of unit sales) and offers products to entry-level, move-up, and active-adult buyers. PulteGroup offers homebuyers mortgage financing and title agency services through its financial services segment. The company is headquartered in Atlanta.
Read more on PHM →
